期刊文献+

甲状腺乳头状癌伴和不伴桥本甲状腺炎患者的BRAFV600E突变及侵袭性研究的meta分析 被引量:5

Study on BRAF V600E mutation and invasion in papillary thyroid carcinoma with or without Hashimoto′s thyroiditis:a meta analysis
下载PDF
导出
摘要 目的评估桥本甲状腺炎(HT)与甲状腺乳头状癌(PTC)患者的BRAF突变率和侵袭性。方法使用计算机检索中国期刊全文数据库、万方数据库、中文科技期刊数据库,以及PubMed等英文数据库,收集包含PTC,HT和BRAF突变等相关关系的中英文文献,应用RevMan5.3软件对数据进行meta分析。结果共纳入文献10篇,涉及PTC病例4 265例。meta分析结果显示:与PTC组相比,PTC合并HT组的BRAF突变率,甲状腺外侵犯率和淋巴结转移率显著降低(P<0.05);当BRAF突变存在时,PTC合并HT组的甲状腺外侵犯率仍然显著低于PTC组(P<0.05),但是两组的淋巴结转移率比较差异无统计学意义(P>0.05)。结论与不合并HT的PTC患者相比,合并HT的PTC患者表现出较低的BRAF突变率和侵袭性,即使是在BRAF阳性突变存在时,HT仍能在一定程度上阻碍PTC的进展和侵袭性。 Objective To evaluate the BRAF mutation rate and invasion in the patients with papillary thyroid carcinoma(PTC)and the patients with Hashimoto thyroiditis(HT).Methods The databases of CNKI,Wanfang,VIP and PubMed English databases were retrieved by computer for collecting the Chinese and English literatures containing PTC,HT and BRAF mutation.The meta analysis was performed by using RevMan 5.3 software.Results A total of 10 articles involving 4 265 PTC patients were included.The meta analysis results showed that compared with the PTC group,the BRAF mutation rate,invasion rate outside thyroid gland and lymph node metastasis rate in the PTC complicating HT group were significantly decreased(P<0.05);when BRAF mutation existed,the invasion rate outside thyroid gland in the PTC complicating HT group was significantly lower than that in the PTC group(P<0.05),but the lymph node metastasis rate had no statistical difference between the two groups(P>0.05).Conclusion Compared with the PTC patients without complicating HT,the patients with PTC complicating HT show lower BRAF mutation rate and low invasiveness,even the BRAF positive mutation exists,HT can hinder the progression and invasiveness of PTC to a certain extent.
作者 唐雯 尚恒 李彦国 庞雅贤 何雪娟 TANG Wen;SHANG Heng;LI Yanguo;PANG Yaxian;HE Xuejuan(Teaching and Researching Section of Preventive Medicine,Cangzhou Medical College,Cangzhou,Hebei 061000,China;Department of Endocrinology,Cangzhou Municipal People′s Hospital,Cangzhou,Hebei 061000,China)
出处 《重庆医学》 CAS 2018年第36期4614-4618,共5页 Chongqing medicine
基金 2015年度河北省科技计划资助项目(152777167)
关键词 桥本甲状腺炎 乳头状 BRAF META分析 Hashimoto′s thyroiditis carcinoma,papillary BRAF meta analysis
  • 相关文献

参考文献5

二级参考文献91

  • 1王建红,王正滨,房世保,李萍,孙咏梅,禹静,杨雪,牛晓燕.桥本甲状腺炎合并多灶性甲状腺乳头状癌的超声诊断价值[J].中华医学超声杂志(电子版),2013,10(7):596-598. 被引量:14
  • 2闫慧娴,谷伟军,杨国庆,黄薇,巴建明,王先令,杜锦,金楠,臧丽.桥本甲状腺炎与甲状腺乳头状癌关系的临床研究[J].中华内分泌代谢杂志,2014,30(4). 被引量:51
  • 3钱碧云,陈可欣,何敏,董淑芬,韩宏伟,雷蕾,王继芳.天津市区甲状腺癌流行状况调查[J].中国肿瘤临床,2005,32(4):218-221. 被引量:56
  • 4朱晓丽,周晓燕,朱雄增.甲状腺乳头状癌中BRAF^(V599E)点突变与RET/PTC融合基因的检测[J].中华病理学杂志,2005,34(5):270-274. 被引量:30
  • 5Kim SJ, Lee KE, MyongJP, et al. BRAFV600E mutation is associat- ed with tumor aggressiveness in papillary thyroid cancer[J].World J Surg, 2012, 36(2): 310-317.
  • 6Frasca F, Nucera C, Pellegriti G, et al. BRAFV600E mutation and the biology of papillary thyroid cancer[J]. Endocr Relat Cancer, 2008, 15(1): 191-205.
  • 7Kim KH, Kang DW, Kim SH, et al. Mutations of the BRAF gene in papillary thyroid carcinoma in a Korean population[J]. Yonsei MedJ, 2004, 45(5): 818-821.
  • 8Proietti A, Giannini R, Ugolini C, et al. BRAF status of follicular variant of papillary thyroid carcinoma and its relationship to its clin- ical and cytological features[J]. Thyroid, 2010, 20(11): 1263-1270.
  • 9Xing M, Westra WH, Tufano RP, et al. BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer[J]. J Clin Endo- crinol Metab, 2005, 90(12): 6373-6379.
  • 10Sassolas G, Hafdi-Nejjari Z, Ferraro A, et al. Oncogenic alterations in papillary thyroid cancers of young patients[J].Thyroid, 2012, 22 (1): 17-26.

共引文献26

同被引文献42

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部